PReS-FINAL-2232: Long-term follow-up in a national cohort of MKD patients: search for clinical predictors of a spontaneous improvement by Doglio, M et al.
See	discussions,	stats,	and	author	profiles	for	this	publication	at:	https://www.researchgate.net/publication/274891257
PReS-FINAL-2232:	Long-term	follow-up	in	a
national	cohort	of	MKD	patients:	search	for
clinical	predictors	of	a	spontane....
Article		in		Pediatric	Rheumatology	·	December	2013
DOI:	10.1186/1546-0096-11-S2-P222
CITATION
1
READS
28
15	authors,	including:
Some	of	the	authors	of	this	publication	are	also	working	on	these	related	projects:
Fabry	disease	View	project
neutrophilic	dermatosis	View	project
Matteo	Doglio
Università	degli	Studi	di	Genova
11	PUBLICATIONS			29	CITATIONS			
SEE	PROFILE
Silvia	Federici
IRCCS	Istituto	G.	Gaslini
51	PUBLICATIONS			969	CITATIONS			
SEE	PROFILE
Alberto	Tommasini
IRCCS	Ospedale	Infantile	Burlo	Garofolo
174	PUBLICATIONS			3,202	CITATIONS			
SEE	PROFILE
Antonella	Meini
Spedali	Civili	di	Brescia
99	PUBLICATIONS			2,191	CITATIONS			
SEE	PROFILE
All	content	following	this	page	was	uploaded	by	Antonella	Meini	on	30	August	2015.
The	user	has	requested	enhancement	of	the	downloaded	file.
POSTER PRESENTATION Open Access
PReS-FINAL-2232: Long-term follow-up in a
national cohort of MKD patients: search for
clinical predictors of a spontaneous improvement
M Doglio1*, S Federici1, A Tommasini2, A Meini3, M Cattalini3, L Obici4, L Cantarini5, F Zulian6, L Breda7,
R Consolini8, F Corona9, A Insalaco10, D Rigante11, A Martini1, M Gattorno1
From 20th Pediatric Rheumatology European Society (PReS) Congress
Ljubljana, Slovenia. 25-29 September 2013
Introduction
Mevalonate-kinase deficiency (MKD) is an autosomal
recessive disease caused by the deficiency of the mevalo-
nate-kinase enzyme (MVK) and characterized by recurrent
fever episodes with systemic involvement. Classically, the
disease was thought to have a self-limiting course, with a
spontaneous improvement in the adulthood. In 2008 the
International registry showed that 50% of patients present
a reduction of fever episodes in the adulthood. Up to now,
it’s difficult to predict the course of the disease a patient
will display.
Objectives
To identify clinical predictors of a self-improvement
course of MKD.
Methods
Patients carrying two mutations of the MVK gene or a
single mutation with a MKD phenotype were collected
in a national multicentric study. Detailed clinical infor-
mation was collected at the time of molecular analysis
and last follow-up through a standardized questionnaire.
Spontaneous disease course was classified as follows: i)
resolution (no episodes in the last 6 months), ii)
improvement (reduction of more then 30% of fever
episodes), iii) stationary and iv) worsening (increase fre-
quency of fever episodes or appearance of new major
clinical manifestation). A spontaneous improvement was
considered a reduction or resolution of fever episodes
without any maintenance therapy.
Results
We collected baseline information of 56 patients (29M
and 27F). The mean age of onset was 10,5 ± 15,3
months (range 1-108), with a number of fever episodes
per year at the baseline of 13,8 ± 5,4 (range 3-30). The
most frequent mutation was V377I, showed by 43
patients; in 10 patients it was at the homozygous state.
Follow-up information was available for 42 patients; the
mean age of the patients was 13,3 ± 8,5 years, the mean
disease duration was 12,4 ± 8,7 years. At the follow-up
the mean number of fever per year was 8,8 ± 6,7.
Twelve patients (28,6%) showed a spontaneous improve-
ment of the disease at the follow-up, fifteen (35,7%)
remained stable and seven (16,7%) worsened. Thirteen
patients required a biologic therapy: five patients
improved with Anakinra and no one with Etanercept.
The variables associated with a spontaneous improve-
ment were: female sex (p = 0.019), V377I at the homozy-
gous state (p = 0.03). The same patients display also a less
frequent presence of some clinical manifestations at the
last follow-up, such as exudative pharyngitis (p = 0,03),
painful lymph nodes (p =0,02) and vomiting (p = 0,03).
Multivariate analysis indicated as predictors of sponta-
neous improvement: female sex (p = 0,007) and V377I at
the homozygous state (p = 0,0003).
Conclusion
The homozygous state for V377I and female sex are
associated to a spontaneous improvement of disease
course in MKD patients. These elements could help
clinicians to establish which patients could be exclu-
sively treated with steroid on demand in respect to
those that could take advantage from the early use of
2nd line treatment with biologics.
1Pediatria 2, IRCCS ISTITUTO GIANNINA GASLINI, Genoa, Italy
Full list of author information is available at the end of the article
Doglio et al. Pediatric Rheumatology 2013, 11(Suppl 2):P222
http://www.ped-rheum.com/content/11/S2/P222
© 2013 Doglio et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Disclosure of interest
None declared.
Authors’ details
1Pediatria 2, IRCCS ISTITUTO GIANNINA GASLINI, Genoa, Italy. 2IRCCS Burlo
Garofolo, Trieste, Italy. 3Spedali Civili, Brescia, Italy. 4Ospedale S. Matteo, Pavia,
Italy. 5Ospedale Santa Maria alle Scotte, Siena, Italy. 6Salus Pueri, Padova, Italy.
7Policlinico SS. Annunziata, Chieti, Italy. 8Stabilimento di Santa Chiara, Pisa,
Italy. 9Ospedale Maggiore Policlinico, Milan, Italy. 10Ospedale Bambino Gesù,
Rome, Italy. 11Policlinico Gemelli, Rome, Italy.
Published: 5 December 2013
doi:10.1186/1546-0096-11-S2-P222
Cite this article as: Doglio et al.: PReS-FINAL-2232: Long-term follow-up
in a national cohort of MKD patients: search for clinical predictors of a
spontaneous improvement. Pediatric Rheumatology 2013 11(Suppl 2):P222.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Doglio et al. Pediatric Rheumatology 2013, 11(Suppl 2):P222
http://www.ped-rheum.com/content/11/S2/P222
Page 2 of 2
View publication stats
